Search Within

Heather Jolie Landau

  1. "Myeloma"
Formats
  1. Meeting Abstract (175)
  2. Journal Article (56)
  3. Research Letter (6)
  4. Book Section (1)
  5. Correspondence (1)
Groups
  1. Bone Marrow Transplant (239)
  2. Center for Hematologic Malignancies (239)
  3. Department of Medicine (239)
  4. Hematologic Malignancies, Division of (239)
  5. Myeloma (239)
  6. Survivorship Research (239)

More Groups

People
  1. Hani Hassoun (216)
  2. Sergio Giralt (192)
  3. Alexander Lesokhin (177)
  4. David Chung (175)
  5. Neha Korde (137)
  6. Sham Mailankody (137)

More People

Years
  1. 2025 (2)
  2. 2024 (29)
  3. 2023 (34)
  4. 2022 (31)
  5. 2021 (13)
  6. 2020 (15)

More Years

Publications
  1. Blood (101)
  2. Clinical Lymphoma, Myeloma and Leukemia (43)
  3. Biology of Blood and Marrow Transplantation (23)
  4. Leukemia and Lymphoma (11)
  5. Journal of Clinical Oncology (10)
  6. Blood Cancer Journal (6)

More Publications

Publishers
  1. American Society of Hematology (106)
  2. Elsevier Inc. (70)
  3. Nature Publishing Group (16)
  4. Taylor & Francis Group (14)
  5. American Society of Clinical Oncology (10)
  6. American Association for Cancer Research (4)

More Publishers

Results (239)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gain of chromosome 1q portends worse prognosis in multiple myeloma patients treated with novel agent based induction regimens even after autologous transplantation
    Meeting Abstract

    Shah, G. L.; Landry, C.; Londono, D.; Devlin, S.; Kosuri, S.; Lesokhin, A. M.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Therapy-related B-lymphoblastic leukemia evolving during lenalidomide maintenance for multiple myeloma
    Meeting Abstract

    Sae-Ow, W.; Roshal, M.; Landau, H.; Lesokhin, A.; Pichardo, J.; Park, J.; Landgren, C. O.; Maslak, P.; Dogan, A.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Therapy-related B-lymphoblastic leukemia evolving during lenalidomide maintenance for multiple myeloma
    Meeting Abstract

    Sae-Ow, W.; Roshal, M.; Landau, H.; Lesokhin, A.; Pichardo, J.; Park, J.; Landgren, C. O.; Maslak, P.; Dogan, A.
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Interim analysis of a randomized phase II trial comparing continuous lenalidomide and dexamethasone to autologous stem cell transplantation in multiple myeloma patients responsive to lenalidomide and dexamethasone induction
    Meeting Abstract

    Weltz, J. I.; Landau, H.; Lendvai, N.; Chung, D. J.; Lesokhin, A. M.; Devlin, S. M.; Riedel, E.; Woo, K. M.; Stellman, A.; Chimento, D.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Efficacy and risk factors analysis of upfront autologous stem cell mobilization using plerixafor and granulocyte-colony stimulating factor (GCSF) in patients with multiple myeloma
    Meeting Abstract

    Ogunniyi, A.; Rodriguez, M.; Devlin, S. M.; Adel, N. G.; Landau, H.; Chung, D. J.; Lendvai, N.; Lesokhin, A. M.; Landgren, O.; Giralt, S. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Increased bone marrow plasma cells at diagnosis predicts overall mortality in AL amyloidosis patients undergoing risk-adapted stem cell transplant
    Meeting Abstract

    Landry, C. A.; Smith, M.; Chou, J. F.; Devlin, S. M.; Hassoun, H.; Bello, C.; Landgren, O.; Giralt, S.; Comenzo, R. L.; Landau, H.
    Blood (2014)

    Fulltext@MSK | Save
  • Greater total dose and duration of treatment with bortezomib are associated with higher incidence of chalazion and other ocular side effects
    Meeting Abstract

    Ganesh, K.; Batlevi, C.; Zhang, Z. G.; Hassoun, H.; Lendvai, N.; Landau, H.; Moskowitz, C. H.; Caron, P.; Motzer, R.; Giralt, S. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Analysis of VDT-PACE utilization in multiple myeloma patients treated at MSKCC for relapsed disease or cytoreduction and stem cell mobilization after initial induction therapy
    Meeting Abstract

    Beyer, K.; Rosner, S.; Woo, K. M.; Devlin, S. M.; Landau, H.; Hassoun, H.; Lendvai, N.; Chung, D. J.; Adel, N. G.; Puto, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for autologous stem cell mobilization in multiple myeloma patients: An update on cost analysis study at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Afifi, S.; Adel, N. G.; Duck, E.; Devlin, S. M.; Landau, H.; Lendvai, N.; Lesokhin, A. M.; Chung, D. J.; Landgren, O.; Giralt, S. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Plasma cell disorders
    Book Section

    Burke, P. W.; Hassoun, H.; Palomba, M. L.; Kumar, A.; Landau, H. J.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save